Pityriasis Rosea Induced by COVID-19 Vaccination.
Eur J Case Rep Intern Med
; 9(2): 003164, 2022.
Article
in English
| MEDLINE | ID: covidwho-1737377
ABSTRACT
It is increasingly recognized that SARS-CoV-2 infection and COVID-19 vaccines have been associated with skin disorders, including pityriasis rosea. It has been reported that pityriasis rosea has been triggered by several vaccines, as a rare side-effect. We present two cases of COVID-19 vaccine-induced pityriasis rosea. Skin lesions appeared in a 49-year-old female 8 days after the first dose of the BNT162b2 mRNA vaccine and in a 53-year-old male 7 days after the second dose of the same vaccine. The exanthem was self-limited in both patients over a period of a month. LEARNING POINTS Physicians should be aware that pityriasis rosea is a rare side-effect of COVID-19 vaccination.Pityriasis rosea is self-limiting and no medical treatment is usually required.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Vaccines
Language:
English
Journal:
Eur J Case Rep Intern Med
Year:
2022
Document Type:
Article
Affiliation country:
2022_003164
Similar
MEDLINE
...
LILACS
LIS